Kristi Egland

Title: Kristi Egland: Innovator in Breast Cancer Detection

Introduction

Kristi Egland is a prominent inventor based in Sioux Falls, SD (US). She has made significant contributions to the field of medical diagnostics, particularly in breast cancer detection. Her innovative work has the potential to improve early detection and treatment outcomes for patients.

Latest Patents

Kristi holds a patent for "Reagents and methods for breast cancer detection." This invention provides compositions that include reagents for detecting human autoantibodies against a selection of proteins. These proteins include ANGTPL4, DKK1, EPHA2, LAMC2, SPON2, SSR2, GAL1, GFRA1, LRRC15, CD147, CD320, CDH3, LRP10, SPINT2, SUSD2, and CST2. The patent focuses on their use in detecting breast cancer or disease recurrence, showcasing her commitment to advancing cancer diagnostics.

Career Highlights

Kristi is affiliated with Sanford Health, where she continues to work on innovative solutions in healthcare. Her dedication to research and development has positioned her as a key figure in her field. With a patent portfolio that includes 1 patent, she exemplifies the impact that focused research can have on medical science.

Collaborations

Kristi collaborates with notable colleagues, including Rick Evans and James Viktor Pottala. Their combined expertise enhances the research environment and fosters innovation within their projects.

Conclusion

Kristi Egland's contributions to breast cancer detection highlight her role as an influential inventor in the medical field. Her work not only advances scientific knowledge but also has the potential to save lives through improved diagnostic methods.